4DX.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: April 24, 2026
Report Source: 2026 2nd Quarter Report
4DMedical Ltd. Stock Analysis 4DX.AX
4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. Leveraging its proprietary XV Technology and Imbio Technology, the Company provides cutting-edge thoracic imaging that enhances physician diagnoses and management of respiratory conditions. XV technology delivers detailed insights to airflow, lung structure, and regional lung function through a patient’s complete breath cycle. The company produces software and hardware products that enable new levels of non-invasive, quantitative analysis of lung function. Its products include CAC (Coronary Artery Calcification), CT-LVAS (Computed Tomography Lung Ventilation Analysis Software), IQ-UIP, LDAf (Functional Lung Density Analysis), LDAi (Lung Density Analysis-Inspiration), LTA (Lung Texture Analysis), PHA Analysis (Pulmonary Hypertension Assessment), XV LVAS (X-ray Velocimetry Lung Ventilation Analysis Software), and XV Scanner.
Read More 4DMedical Ltd (4DX.AX) Chart
Key Statistics of 4DMedical Ltd (4DX.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD3.85Volume
13.57MP/E Ratio (TTM)
-52 Week Range
Market Cap
2.42BAvg. Volume
758.21KDividend Yield
-Financial Metrics & Statements of 4DMedical Ltd (4DX.AX)
FAQ's for 4DMedical Ltd (4DX.AX)
- According to Musaffa’s Shariah screening methodology, 4DMedical Ltd (4DX.AX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.